Jiaping Zhang

Title: Jiaping Zhang: Innovator in Chimeric Human Papillomavirus Production

Introduction

Jiaping Zhang is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of virology, particularly in the production of chimeric human papillomavirus (HPV). His work has implications for both research and potential therapeutic applications.

Latest Patents

Jiaping Zhang holds a patent for the "Production of chimeric human papillomavirus." This invention relates to infectious chimeric papillomaviruses, specifically those where the early genes are derived from human papillomavirus (HPV) 18, while the late genes come from another HPV strain. The patent also presents methods for culturing the virus in raft cell cultures and assays utilizing these chimeric viruses.

Career Highlights

Jiaping Zhang is currently employed at Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative research in the field of infectious diseases, contributing to advancements in vaccine development and therapeutic strategies.

Collaborations

Throughout his career, Jiaping Zhang has collaborated with esteemed colleagues, including Robert S. Lowe and Craig M. Meyers. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Jiaping Zhang's contributions to the production of chimeric human papillomavirus highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the field of virology and offers promising avenues for future research and development.